Insider · CIK 0001597085

Egros Fabrice

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001597085

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-02	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+16K sh	—	—	32,000
2021-11-18	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+14K sh	$8.93	+$125K	30,000
2021-11-18	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−14K sh	$18.03	−$252K	16,000
2021-11-18	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+30 sh	$7.88	+$236.4	16,030
2021-11-18	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−30 sh	$18.03	−$540.969	16,000
2021-11-18	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−14K sh	—	—	0
2021-11-18	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30 sh	—	—	0
2021-08-18	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+15.6K sh	$7.88	+$123K	31,635
2021-08-18	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−15.6K sh	$15.75	−$246K	16,000
2021-08-18	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.6K sh	—	—	0
2021-05-18	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	$7.20	+$85.9K	27,926
2021-05-18	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+1,683 sh	$7.88	+$13.3K	29,609
2021-05-18	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−11.9K sh	$18.65	−$222K	17,683
2021-05-18	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−1,683 sh	$18.65	−$31.4K	16,000
2021-05-18	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,683 sh	—	—	0
2021-05-18	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	0
2021-03-01	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+10.2K sh	$6.35	+$64.6K	26,167
2021-03-01	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+74 sh	$7.20	+$532.8	26,241
2021-03-01	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−10.2K sh	$24.31	−$247K	16,074
2021-03-01	SNDXSyndax Pharmaceuticals IncS Sale	Director	SSale	−74 sh	$24.31	−$1,799.103	16,000
2021-03-01	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−74 sh	—	—	0
2021-03-01	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.2K sh	—	—	0
2021-02-03	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+16K sh	—	—	16,000
2020-02-12	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2019-06-10	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2018-05-23	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2018-02-08	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-05-17	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-05-17	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2016-10-31	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000

Recent filings

Accepted (ET)
Feb 34
Egros Fabrice0001562180-22-001072
SEC(opens sec.gov)
Nov 194
Egros Fabrice0001562180-21-007180
SEC(opens sec.gov)
Aug 204
Egros Fabrice0001562180-21-005491
SEC(opens sec.gov)
May 204
Egros Fabrice0001562180-21-003670
SEC(opens sec.gov)
Mar 34
Egros Fabrice0001562180-21-001909
SEC(opens sec.gov)

Companies

Syndax Pharmaceuticals IncDirectorSNDX

Address

C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110

WALTHAM, MA, 02451